toxylact

The first professional lActological database in the word

Opium preparations (ATC A07DA02) are opioid‑based antipropulsives (including opium tincture and related mixtures) used for short‑term symptomatic treatment of severe or refractory diarrhea, but because they and their constituents (notably morphine and codeine) readily pass into breast milk and can depress the infant’s central nervous and respiratory systems, they are generally not recommended in breastfeeding and should be avoided in favor of safer alternatives.atcddd.fhi+4

ATC A07DA02 overview

ATC code A07DA02 “Opium” belongs to the antipropulsives subgroup, defined as agents that reduce gastrointestinal motility. This code explicitly includes opium preparations and combinations with belladonna, bismuth subgallate, albumin and similar excipients, with defined daily doses based on treatment of acute diarrhea.atcddd.fhi+2

Pharmacology and mechanism

Opium is a complex natural mixture containing morphine, codeine and other opium alkaloids; its antidiarrheal effect is mediated mainly through μ‑opioid receptor activation in the gut. By reducing intestinal motility and prolonging transit time, opium increases contact time between luminal fluid and mucosal cells, thereby increasing net fluid absorption and reducing stool volume, as shown for codeine in experimental diarrhea studies.pubmed.ncbi.nlm.nih+5

Therapeutic indications

Within A07DA02, opium tincture is indicated as symptomatic treatment for severe diarrhea in adults when other therapies (such as loperamide and non‑opioid measures) have failed. In chronic diarrhea (for example short bowel syndrome or refractory functional diarrhea), opium tincture has demonstrated anti‑propulsive effects with reduced bowel movements and prolonged colonic transit time in selected patients, but its use is reserved for carefully monitored cases.farmacotherapeutischkompas+2

Dosage and administration

Adult dosing of opium tincture for severe diarrhea typically begins at 5–10 drops (approximately 2.5–5 mg opium) 2–3 times daily, with maximum single doses around 1 ml and maximum daily doses of up to 6 ml, depending on local product strength. Pharmacology guidance notes that 1 ml of opium tincture is roughly equivalent to about 65 mg codeine or 10 mg morphine in antidiarrheal potency, underscoring the significant opioid load even at small volumes.farmacotherapeutischkompas+1

Pharmacokinetics relevant to lactation

Morphine and codeine are well absorbed orally and widely distributed, with substantial plasma levels even at therapeutic doses. Lactation data show that opium alkaloids can appear in breast milk at concentrations higher than maternal plasma, indicating efficient transfer into milk and potential exposure of the breastfed infant to clinically relevant opioid levels.ncbi.nlm.nih+2

Maternal safety and adverse effects

Adverse effects of opium antidiarrheals reflect opioid pharmacology: constipation, nausea, vomiting, dizziness and sedation are common, and higher doses or prolonged use increase the risks of dependence and respiratory depression. Belladonna or other anticholinergic co‑components may add dry mouth, blurred vision, tachycardia and urinary retention, further complicating the safety profile in vulnerable patients.atcddd.fhi+2

Lactation safety assessment

Authoritative formularies advise avoiding opium in breastfeeding because it is present in milk at higher concentrations than maternal plasma and can affect the breastfed infant; if use cannot be avoided, they recommend close infant monitoring for opioid toxicity. Breastfeeding‑specific antidiarrheal guidance similarly states that opium‑based antidiarrheals are not recommended in lactation due to scant safety data and the known risks of codeine‑like opioids in infants.who+2

Potential effects on the breastfed infant

The primary infant risks from maternal A07DA02 opium use are sedation, poor feeding, hypotonia and respiratory depression, including rare cases of apnea, reflecting opioid exposure via breast milk. Codeine‑related experiences in breastfeeding (including severe infant toxicity in ultra‑rapid metabolizer mothers) reinforce the concern that opioid components in opium may unpredictably accumulate in infants, especially neonates and preterm babies.who+4

Practical recommendations in breastfeeding

For breastfeeding women with acute diarrhea, best practice is to continue breastfeeding, use oral rehydration salts to correct fluid and electrolyte losses, and, when a motility‑reducing drug is needed, choose loperamide, which has minimal milk transfer and negligible infant bioavailability. Opium antidiarrheals (A07DA02) should generally be avoided during breastfeeding; if an exceptional case arises where their use is judged essential in a mother of an older, full‑term infant, the lowest effective dose and shortest course should be used, with explicit counseling and vigilant monitoring of the infant for signs of opioid toxicity, and immediate discontinuation plus medical review if symptoms occur.ncbi.nlm.nih+5

Role within antidiarrheal therapy

Within the antipropulsives subgroup, opium preparations offer potent symptom control but carry significantly higher central‑opioid risk compared to peripheral agents such as loperamide, particularly in lactating women and infants. In a toxico‑lactological framework, their benefit in refractory adult diarrhea does not justify routine use in breastfeeding; they are best considered second‑ or third‑line rescue options for non‑lactating adults with chronic severe diarrhea when safer and non‑opioid strategies have failed.pubmed.ncbi.nlm.nih+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.